Pubblicazioni scientifiche

Pubblicazioni scientifiche

 

Bordignon M, Castellani C, Fedrigo M, Thiene G, Peserico A, Alaibac M, Angelini A. Role of alpha5beta1 integrin and MIA (melanoma inhibitory activity) in the pathogenesis of vitiligo. J Dermatol Sci. 2013 Apr 17. doi:pii: S0923-1811(13)00120-5.

 

Belloni-Fortina A, Piaserico S, Bordignon M, Gambato M, Senzolo M, Paolo Russo F, Peserico A, De Matteis G, Perissinotto E, Cillo U, Vitale A, Alaibac M, Burra P. Skin cancer and other cutaneous disorders in liver transplant recipients. Acta Derm Venereol. 2012 Mar 1. doi: 10.2340/00015555-1316.

 

Bordignon M , Rottoli P, Agostini C, Alaibac M. Adaptive immune responses in primary cutaneous sarcoidosis. Clin Dev Immunol. 2011;2011:235142. Epub 2011 Mar 30. PMID: 216031 92.


Zattra E, Zambello R, Marino F, Bordignon M, Alaibac M. Primary Cutaneous Mantle Cell Lymphoma. Acta Derm Venereol. 2011 May 3. PMID: 21537825.

 

Roxana Stan T, Piaserico S, Bordignon M, Salmaso R, Zattra E, Alaibac M. Bullous scabiei simulating pemphigoid. Cutan Med Surg 2011; 15: 55-7.

 

Corradin MT, Forcione M, Fiorentino R, Bordignon M, Alaibac M, Belloni-Fortina A. Verrucous cutaneous sarcoidosis in an adolescent with dark skin. Eur J Dermatol 2010; PMID: 20610376.

 

Bordignon M, Viel G, Peserico A, Alaibac M. Non-alcoholic fatty liver disease, alcohol intake and psoriasis. J Hepatol 2010; 53: 586.

 

Bordignon M, Belloni-Fortina A, Pigozzi B, Saponeri A, Alaibac M. The role of immunohistochemical analysis in the diagnosis of parapsoriasis. Acta Histochem. 2010; PMID: 20083298.

 

Bordignon M, Zattra E, Albertin C, Belloni-Fortina A. Successful treatment of a 9-year-old boy affected by acrodermatitis continua of Hallopeau with targeted ultraviolet B narrow-band phototherapy. Photodermatol Photoimmunol Photomed 2010; 26: 41-3.

 

Belloni-Fortina A, Faggion D, Pigozzi B, Peserico A, Bordignon M, Baldo V, Alaibac M. Detection of autoantibodies against recombinant desmoglein 1 and 3 molecules in patients with pemphigus vulgaris: correlation with disease extent at the time of diagnosis and during follow-up. Clin Dev Immunol. 2009; 187864. Epub 2009 Dec 10

 

Bordignon M, Belloni-Fortina A, Pigozzi B, Tarantello M, Alaibac M. Bullous Pemphigoid during Long-Term TNF-alpha Blocker Therapy. Dermatology. 2009; 219: 357-8.

 

Zattra E, Pigozzi B, Bordignon M, Marino F, Chiarion-Sileni V, Alaibac M. Anetoderma in cutaneous marginal-zone B-cell lymphoma. Clin Exp Dermatol. 2009; 34: e945-8.

 

Sartore L, Bordignon M, Bassetto F, Voltan A, Tomat V, Alaibac M. Melanoma of the hand dorsum on keratodermia palmo-plantaris hereditaria (Mal de Meleda) with preservation of skin autograft. J Am Acad Dermatol 2009; 61: 161-3.

 

Zattra E, Belloni Fortina A, Bordignon M, Piaserico S, Alaibac M. Immunosuppression and melanocyte proliferation. Melanoma Res 2009; 19: 63-8.

 

Belloni AF, Montesco MC, Piaserico S, Bordignon M, Tona F, Feltrin G, Alaibac M. Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma in a Heart Transplant Patient: Report of a Case and Literature Review. Acta Derm Venereol 2009; 89: 74–77.

 

Alaibac M, Pigozzi B, Bordignon M. Is Sezary syndrome a true cutaneous lymphoma?. Int J Dermatol. 2008; 47:1195-6.

 

Bordignon M, Bellon-Fortina A, Pigozzi B, Alaibac M. γδ T cells as potential contributors to the progression of parapsoriasis to mycosis fungoides. Molec Med Rep 2008; 1(4): 485-488.

 

Alaibac M, Bordignon M, Pennelli N, Aversa S, Fornasa CV, Chiarion V. Primary Subcutaneous B-cell Lymphoma: Case Report and Literature Review. Acta Derm Venereol. 2008;88(2):151-4.

 

Bordignon M, Zattra E, Montesco MC, Alaibac M. Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) with absence of desmoglein 1 and 3 antibodies: case report and literature review. Am J Clin Dermatol. 2008;9(1):51-5.

 

Alaibac M, Pigozzi B, Bordignon M. The role of γδ T cells in human cutaneous oncology. Expert Rev Dermatol 2006; 1,293-301.

 

Pigozzi B, Bordignon M, Belloni Fortina A, Michelotto G, Alaibac M. Expression of the CD1a molecule in B- and T-lymphoproliferative skin conditions. Oncol Rep. 2006 Feb;15(2):347-51.